BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8894099)

  • 1. Inhibition of steroid C17(20) lyase with C-17-heteroaryl steroids.
    Burkhart JP; Gates CA; Laughlin ME; Resvick RJ; Peet NP
    Bioorg Med Chem; 1996 Sep; 4(9):1411-20. PubMed ID: 8894099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 21,21-difluoro-3 beta-hydroxy-20-methylpregna-5,20-diene and 5,16,20-triene as potential inhibitors of steroid C17(20) lyase.
    Weintraub PM; Holland AK; Gates CA; Moore WR; Resvick RJ; Bey P; Peet NP
    Bioorg Med Chem; 2003 Feb; 11(3):427-31. PubMed ID: 12517438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroselective synthesis of some steroidal oxazolines, as novel potential inhibitors of 17alpha-hydroxylase-C17,20-lyase.
    Ondré D; Wölfling J; Tóth I; Szécsi M; Julesz J; Schneider G
    Steroids; 2009; 74(13-14):1025-32. PubMed ID: 19666042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20-amino and 20,21-aziridinyl pregnene steroids: development of potent inhibitors of 17 alpha-hydroxylase/C17,20-lyase (P450 17).
    Njar VC; Hector M; Hartmann RW
    Bioorg Med Chem; 1996 Sep; 4(9):1447-53. PubMed ID: 8894102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17 alpha-hydroxylase/C17-20-lyase) and 5 alpha-reductase types 1 and 2.
    Hartmann RW; Hector M; Haidar S; Ehmer PB; Reichert W; Jose J
    J Med Chem; 2000 Nov; 43(22):4266-77. PubMed ID: 11063622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of 17α-hydroxylase-C17,20-lyase (P45017α) enzyme activities and their inhibition by selected steroidal picolyl and picolinylidene compounds.
    Szabó N; Ajduković JJ; Djurendić EA; Sakač MN; Ignáth I; Gardi J; Mahmoud G; Klisurić OR; Jovanović-Šanta S; Penov Gaši KM; Szécsi M
    Acta Biol Hung; 2015 Mar; 66(1):41-51. PubMed ID: 25740437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel steroidal vinyl fluorides as inhibitors of steroid C17(20) lyase.
    Burkhart JP; Weintraub PM; Gates CA; Resvick RJ; Vaz RJ; Friedrich D; Angelastro MR; Bey P; Peet NP
    Bioorg Med Chem; 2002 Apr; 10(4):929-34. PubMed ID: 11836100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of steroid 17 alpha-hydroxylase and C17,20-lyase in the human testis by epitestosterone.
    Bicíková M; Hampl R; Hill M; Stárka L
    J Steroid Biochem Mol Biol; 1993 Oct; 46(4):515-8. PubMed ID: 8217882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer.
    Potter GA; Barrie SE; Jarman M; Rowlands MG
    J Med Chem; 1995 Jun; 38(13):2463-71. PubMed ID: 7608911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer.
    Njar VC; Kato K; Nnane IP; Grigoryev DN; Long BJ; Brodie AM
    J Med Chem; 1998 Mar; 41(6):902-12. PubMed ID: 9526564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of pregnane derivatives as inhibitors of human testicular 17 alpha-hydroxylase/C17,20-lyase.
    Li JS; Li Y; Son C; Brodie AM
    J Med Chem; 1996 Oct; 39(21):4335-9. PubMed ID: 8863811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 17alpha-hydroxylase/C17-20-lyase (P450 17).
    Hartmann RW; Hector M; Wachall BG; Palusczak A; Palzer M; Huch V; Veith M
    J Med Chem; 2000 Nov; 43(23):4437-45. PubMed ID: 11087568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.
    Recanatini M; Bisi A; Cavalli A; Belluti F; Gobbi S; Rampa A; Valenti P; Palzer M; Palusczak A; Hartmann RW
    J Med Chem; 2001 Mar; 44(5):672-80. PubMed ID: 11262078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-pregnene-3-one-20 beta-carboxaldehyde: a potent inhibitor of 17 alpha-hydroxylase/C17,20-lyase and of 5 alpha-reductase.
    Li J; Li Y; Son C; Banks P; Brodie A
    J Steroid Biochem Mol Biol; 1992 May; 42(3-4):313-20. PubMed ID: 1606043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective synthesis of some 17beta-dihydrooxazinyl steroids, as novel presumed inhibitors of 17alpha-hydroxylase-C17,20-lyase.
    Wölfling J; Oravecz EA; Ondré D; Mernyák E; Schneider G; Tóth I; Szécsi M; Julesz J
    Steroids; 2006 Sep; 71(9):809-16. PubMed ID: 16814336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17 beta-(cyclopropylamino)-androst-5-en-3 beta-ol, a selective mechanism-based inhibitor of cytochrome P450(17 alpha) (steroid 17 alpha-hydroxylase/C17-20 lyase).
    Angelastro MR; Laughlin ME; Schatzman GL; Bey P; Blohm TR
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1571-7. PubMed ID: 2788415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and Functional Evaluation of Clinically Relevant Inhibitors of Steroidogenic Cytochrome P450 17A1.
    Petrunak EM; Rogers SA; Aubé J; Scott EE
    Drug Metab Dispos; 2017 Jun; 45(6):635-645. PubMed ID: 28373265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side-chain cleavage of C21 steroids by testicular microsomal cytochrome P-450 (17 alpha-hydroxylase/lyase): involvement of heme.
    Nakajin S; Hall PF
    J Steroid Biochem; 1983 Sep; 19(3):1345-8. PubMed ID: 6604843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, 17α-hydroxylase-C
    Banday AH; Shameem SA; Banday JA; Ganaie BA
    Anticancer Agents Med Chem; 2018; 18(13):1919-1926. PubMed ID: 29697032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4,5-Dihydro-3-(2-pyrazinyl)naphtho[1,2-c]pyrazole: a potent and selective inhibitor of steroid-17 alpha-hydroxylase-C17,20-lyase (P450 17).
    Hartmann RW; Wächter GA; Sergejew T; Würtz R; Düerkop J
    Arch Pharm (Weinheim); 1995; 328(7-8):573-5. PubMed ID: 7492261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.